Zydus Lifesciences Ltd

  • BSE Code : 532321
  • NSE Symbol : ZYDUSLIFE
  • ISIN : INE010B01027
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 974.95 -7.80(-0.79%)

Open Price ()

986.95

Prev. Close ()

982.75

Volume (No’s)

726,018

Market Cap ()

98,102.78

Low Price ()

969.95

High Price ()

986.95

 

Board Meetings

Start Date End Date Purpose
16-Jun-2025 16-Jun-2025 Change in Senior Management
09-May-2025 20-May-2025 Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve audited financial results for the quarter / year ended on March 31 2025 and to recommend final dividend for the financial year ended on March 31 2025. Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31, 2025 The Board also recommended final dividend of Rs. 11/- (@1100%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 12, 2025. (As Per BSE Announcement Dated on 20.05.2025)
11-Mar-2025 11-Mar-2025 Acquisition of shares of Amplitude Surgical SA, France, a listed entity
21-Jan-2025 05-Feb-2025 Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve unaudited financial results of the Company for the quarter / nine months ended on December 31 2024. Unaudited financial results for the quarter / nine months ended on December 31, 2024 (As Per BSE Announcement Dated on: 05/02/2025)
27-Dec-2024 27-Dec-2024 Update on acquisition of a business

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew